Today BioPharma users leverage the power of Genome Trax to identify human genome variations of functional significance by mapping their NGS data to known elements such as disease mutations and regulatory sites. This webinar with Dr. Andreas Kremer from ERASMUS Medical Center, discusses the next generation sequencing data analysis tool and how Genome Trax is able to transform the NGS data.
About the Speaker:
Dr. Andreas Kremer is a Genome Trax user at the bioinformatics department of ERASMUS Medical Center in the Netherlands.
Learn about:
- Prioritizing mutations from whole exome or whole genome sequencing
- Impact of your human variant on disease risk, gene regulation and protein function
- Removing biologically irrelevant mutations and identifying novel ones
- Discovering disease genes, drug targets and pathways linked to your variations
- Gene regulation changes by mapping novel mutations to known
For Research Focused:
Life threatening disease such as oncology, CVD, inflammation, metabolic, CNS, immunology, respiratory, and congenital disorders